Antitumor agent-132
Antitumor agent-132 (Compound F9) is an antitumor agent. Antitumor agent-132 induces cell apoptosis and increases intracellular reactive oxygen species and reduces MMP[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Apoptosis; MMP; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-132.html
Solubility
10 mM in DMSO
Smiles
O=C1OCC2=C1CC[C@@]3(C)C2C[C@H]4[C@@]5([C@]63[C@H]([C@@H]7O[C@@]7([C@H]5OC(CCCCCCCC[N+]8=CC=C(/C=C/C9=CNC%10=CC=CC=C%109)C=C8)=O)C(C)C)O6)O4.[Br-]
Molecular Formula
C44H51BrN2O7
Molecular Weight
799.79
References & Citations
[1]Xing W, et al. Selective Antitumor Effect and Lower Toxicity of Mitochondrion-Targeting Derivatization of Triptolide. J Med Chem. 2024 Jan 3.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog